Table 2. Univariate analysis of prognostic factors and treatment (Cox regression).
| Characteristic | β | s.e. | P-value |
|---|---|---|---|
| Agea | 0.0026 | 0.0053 | 0.6 |
| Sex | |||
| Male | 0 | — | 0.8 |
| Female | −0.04 | 0.12 | |
| WHO performance status | |||
| 0 | 0 | — | <0.001b |
| 1 | 0.32 | 0.14 | |
| 2 | 1.12 | 0.16 | |
| Months since first diagnosis of renal carcinomaa | −0.0040 | 0.0016 | 0.02 |
| Transformed months since first diagnosis of metastasesc | −0.19 | 0.04 | <0.001 |
| Nephrectomy | |||
| No | 0 | — | 0.07 |
| Yes | −0.21 | 0.11 | |
| Metastases | |||
| Single | 0 | — | 0.3 |
| Multiple | 0.17 | 0.15 | |
| Transformed haemoglobind | 35.9 | 4.4 | <0.001 |
| White cell counta | 0.087 | 0.013 | <0.001 |
| Serum calciuma | 0.99 | 0.29 | 0.001 |
| Treatment | |||
| MPA | 0 | — | 0.009 |
| Interferon-α | −0.29 | 0.11 | |
Values of β are log hazard ratios. s.e.=standard error.
Linear function.
Trend test.
Log transformation.
1/haemoglobin.